B. Mohanraj, G.R. Meloni, R.L. Mauck, G.R. Dodge 

Slides:



Advertisements
Similar presentations
Early intervention with Interleukin-1 Receptor Antagonist Protein modulates catabolic microRNA and mRNA expression in cartilage after impact injury  A.A.
Advertisements

Variations in matrix composition and GAG fine structure among scaffolds for cartilage tissue engineering  J.K. Mouw, M.S., N.D. Case, Ph.D., R.E. Guldberg,
Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-α and interleukin-6, but accentuates.
C.P. Neu, T. Novak, K.F. Gilliland, P. Marshall, S. Calve 
IL-10 reduces apoptosis and extracellular matrix degradation after injurious compression of mature articular cartilage  P. Behrendt, A. Preusse-Prange,
The contribution of collagen fibers to the mechanical compressive properties of the temporomandibular joint disc  S. Fazaeli, S. Ghazanfari, V. Everts,
L. Ding, E. Heying, N. Nicholson, N. J. Stroud, G. A. Homandberg, J. A
The beneficial effect of delayed compressive loading on tissue-engineered cartilage constructs cultured with TGF-β3  E.G. Lima, M.Phil., M.S., L. Bian,
Combination of ADMSCs and chondrocytes reduces hypertrophy and improves the functional properties of osteoarthritic cartilage  M.R. Ahmed, A. Mehmood,
Interleukin-1 inhibits osmotically induced calcium signaling and volume regulation in articular chondrocytes  S. Pritchard, Ph.D., B.J. Votta, M.S., S.
Infrapatellar fat pad aggravates degeneration of acute traumatized cartilage: a possible role for interleukin-6  J. He, Y. Jiang, P.G. Alexander, V. Ulici,
Early intervention with Interleukin-1 Receptor Antagonist Protein modulates catabolic microRNA and mRNA expression in cartilage after impact injury  A.A.
A. Watanabe, C. Boesch, S.E. Anderson, W. Brehm, P. Mainil Varlet 
M. Z. Ilic, Ph. D. , B. Martinac, Ph. D. , T. Samiric, Ph. D. , C. J
S. E. Gullbrand, N. R. Malhotra, T. P. Schaer, Z. Zawacki, J. T
Articular chondrocytes derived from distinct tissue zones differentially respond to in vitro oscillatory tensile loading  E.J. Vanderploeg, Ph.D., C.G.
Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-α but not IL-1β treatment at a post-transcriptional level in bovine cartilage.
Analysis of radial variations in material properties and matrix composition of chondrocyte-seeded agarose hydrogel constructs  T.-A.N. Kelly, Ph.D., K.W.
Mechanical loading regimes affect the anabolic and catabolic activities by chondrocytes encapsulated in PEG hydrogels  G.D. Nicodemus, S.J. Bryant  Osteoarthritis.
Functional consequences of glucose and oxygen deprivation on engineered mesenchymal stem cell-based cartilage constructs  M.J. Farrell, J.I. Shin, L.J.
Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage  Peggy M.
Cell deformation behavior in mechanically loaded rabbit articular cartilage 4 weeks after anterior cruciate ligament transection  S.M. Turunen, S.-K.
Interaction between zonal populations of articular chondrocytes suppresses chondrocyte mineralization and this process is mediated by PTHrP  J. Jiang,
M. M. Temple, Ph. D. , W. C. Bae, Ph. D. , M. Q. Chen, M. S. , M
A.J. McGregor, B.G. Amsden, S.D. Waldman  Osteoarthritis and Cartilage 
Functional cartilage repair capacity of de-differentiated, chondrocyte- and mesenchymal stem cell-laden hydrogels in vitro  L. Rackwitz, F. Djouad, S.
Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture  Dr R.L. Mauck, Ph.D., X. Yuan, Dr.
BMP activation and Wnt-signalling affect biochemistry and functional biomechanical properties of cartilage tissue engineering constructs  A. Krase, R.
Contrast Enhanced Computed Tomography can predict the glycosaminoglycan content and biomechanical properties of articular cartilage  P.N. Bansal, N.S.
Biomechanical, structural, and biochemical indices of degenerative and osteoarthritic deterioration of adult human articular cartilage of the femoral.
A.R. Gannon, T. Nagel, D.J. Kelly  Osteoarthritis and Cartilage 
Volume 103, Issue 6, Pages (September 2012)
A. H. Huang, B. S. , M. Yeger-McKeever, M. D. , A. Stein, R. L
P.A. Torzilli, M. Bhargava, S. Park, C.T.C. Chen 
Protective effects of a cathepsin K inhibitor, SB , in the canine partial medial meniscectomy model of osteoarthritis  J.R. Connor, C. LePage, B.A.
Viability and volume of in situ bovine articular chondrocytes—changes following a single impact and effects of medium osmolarity  Dr Peter G. Bush, Ph.D.,
Articular cartilage degeneration following anterior cruciate ligament injury: a comparison of surgical transection and noninvasive rupture as preclinical.
Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis  P.I. Mapp, D.R. Sagar,
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rat  N. Gerwin, A.M. Bendele, S. Glasson,
Inhibition of caspase-9 reduces chondrocyte apoptosis and proteoglycan loss following mechanical trauma  C.A.M. Huser, M.Sc., M. Peacock, M.E. Davies,
Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis  Y. Li, Y. Wang,
The role of cell seeding density and nutrient supply for articular cartilage tissue engineering with deformational loading  R.L. Mauck, C.C-B. Wang, E.S.
Osteogenic protein-1 promotes the formation of tissue-engineered cartilage using the alginate-recovered-chondrocyte method  Dr. K. Masuda, M.D., B.E.
L. Bian, S. L. Angione, K. W. Ng, E. G. Lima, D. Y. Williams, D. Q
J.E. Jeon, K. Schrobback, D.W. Hutmacher, T.J. Klein 
C. Zingler, H.-D. Carl, B. Swoboda, S. Krinner, F. Hennig, K. Gelse 
Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in.
Synergistic effects of growth and differentiation factor-5 (GDF-5) and insulin on expanded chondrocytes in a 3-D environment  B. Appel, J. Baumer, D.
Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion 
The contribution of collagen fibers to the mechanical compressive properties of the temporomandibular joint disc  S. Fazaeli, S. Ghazanfari, V. Everts,
Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress  L Lippiello  Osteoarthritis.
V. Morel, Ph.D., A. Merçay, M.Sc., T.M. Quinn, Ph.D. 
S.I. Paterson, A.K. Amin, A.C. Hall  Osteoarthritis and Cartilage 
Tissue engineering of cartilage using poly-ɛ-caprolactone nanofiber scaffolds seeded in vivo with periosteal cells  M.E. Casper, J.S. Fitzsimmons, J.J.
M. Hufeland, M. Schünke, A.J. Grodzinsky, J. Imgenberg, B. Kurz 
Characterizing osteochondrosis in the dog: potential roles for matrix metalloproteinases and mechanical load in pathogenesis and disease progression 
In vitro glycation of articular cartilage alters the biomechanical response of chondrocytes in a depth-dependent manner  J.M. Fick, M.R.J. Huttu, M.J.
Scaffold degradation elevates the collagen content and dynamic compressive modulus in engineered articular cartilage  K.W. Ng, Ph.D., L.E. Kugler, B.S.,
Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs  J.T. Connelly, Ph.D., C.G. Wilson,
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis  B.Y. Chan, E.S. Fuller, A.K. Russell, S.M. Smith, M.M. Smith,
W.C. Bae, Ph.D., B.L. Schumacher, B.S., R.L. Sah, M.D., Sc.D. 
A single application of cyclic loading can accelerate matrix deposition and enhance the properties of tissue-engineered cartilage  Dr S.D. Waldman, Ph.D.,
Cartilage growth and remodeling: modulation of balance between proteoglycan and collagen network in vitro with β-aminopropionitrile  A. Asanbaeva, Ph.D.,
Tissue engineering with meniscus cells derived from surgical debris
Membrane culture and reduced oxygen tension enhances cartilage matrix formation from equine cord blood mesenchymal stromal cells in vitro  C. Co, M.K.
Estrogen reduces mechanical injury-related cell death and proteoglycan degradation in mature articular cartilage independent of the presence of the superficial.
A.R. Tan, E.Y. Dong, G.A. Ateshian, C.T. Hung 
Mitoprotection as a strategy to prevent chondrocyte death and cartilage degeneration following mechanical injury  M.L. Delco, E.D. Bonnevie, H.H. Szeto,
J.F. Nishimuta, M.E. Levenston  Osteoarthritis and Cartilage 
H. Stenhamre, M. Sc. , K. Slynarski, M. D. , Ph. D. , C. Petrén, T
Presentation transcript:

A high-throughput model of post-traumatic osteoarthritis using engineered cartilage tissue analogs  B. Mohanraj, G.R. Meloni, R.L. Mauck, G.R. Dodge  Osteoarthritis and Cartilage  Volume 22, Issue 9, Pages 1282-1290 (September 2014) DOI: 10.1016/j.joca.2014.06.032 Copyright © 2014 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Injurious compression protocol. (A, B) Engineering strain and stress profiles of CTAs for the four injury protocols tested: 50% or 75% strain applied at either 10% or 50% strain/s for a total compression time (ramp and hold) of 10 s. Profiles are representative of constructs injured in that group (N = 24/group, all CTAs fabricated with pooled chondrocytes of a single animal). (C) Strain and strain rate both significantly influence peak stress, with 75% strain applied at 50% strain/s yielding the highest peak stress. Osteoarthritis and Cartilage 2014 22, 1282-1290DOI: (10.1016/j.joca.2014.06.032) Copyright © 2014 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Effect of strain and strain rate on matrix retention and loss following injury. (A) GAG content normalized to DNA content within CTAs (N = 3/group, all CTAs fabricated with pooled chondrocytes of a single animal) showed consistent loss of matrix following injury applied to 75% strain at 50% strain/s. (B) GAG released to the medium (N = 3/group, all CTAs fabricated with pooled chondrocytes of a single animal) mirrored that of the construct, but with significant loss observed in a strain-dependent manner at both 50% and 75% strain, regardless of the strain rate during injury. (C–E) Live/Dead staining (green: viable; red: non-viable) 24 h post-injury for the highest strain rate illustrated that 50% strain resulted in focal regions of cell death with internal fissuring while control constructs contained viable cells throughout. 75% strain caused more extensive cell death superficially and adjacent to large and full-depth fissures (N = 2/group). (D–F) Alcian blue staining for proteoglycans showed control constructs with well distributed matrix, that 50% strain caused internal fissuring with local matrix loss (black arrows), and that 75% strain caused widespread matrix damage with fainter staining for proteoglycans throughout the construct (N = 2/group). *P vs control and #P vs 50% strain for a respective time point; P < 0.001 for * and # symbols alone. Osteoarthritis and Cartilage 2014 22, 1282-1290DOI: (10.1016/j.joca.2014.06.032) Copyright © 2014 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 High throughput mechanical screening (HTMS) device for applying compressive injuries to CTAs. (A) The HTMS injury device consisted of an aluminum frame with linear bearings to guide the vertical motion of the sensor loading platen. The sensor adhered to the underside of the loading platen comes into contact with a well plate assembly consisting of PTFE indenters aligned with a standard 48-well plate containing engineered constructs. Average sample height was measured prior to testing, with a target injurious compression of 75% strain at 50% strain/s applied to constructs. (B) Example distribution of sample heights and applied strains for each construct (N = 48/plate). Average strain was 78 ± 10% strain for the population. (C) Peak voltage recordings in each well showed the uniformity of peak load responses in engineered cartilage during compressive injury. Osteoarthritis and Cartilage 2014 22, 1282-1290DOI: (10.1016/j.joca.2014.06.032) Copyright © 2014 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 Release of ECM and cellular enzymes and alterations in CTA properties following high-throughput mechanical injury. (A) Injury of engineered cartilage significantly increased GAG release to the medium in a manner similar to that of IL-1 treatment alone for the first 48 h; after 48 h, IL-1 causes a 4–5-fold higher level of GAG release from the construct compared to injury alone (N = 8 media collections per sample combined into 4 aliquots, Sol-GAG is an average value per aliquot/group). (B) LDH release (a measure of cell viability) indicated that injury caused a large increase in chondrocyte membrane disruption in the first 24 h after injury, while IL-1 resulted in little membrane damage with continuous exposure for 5 days (N = 8 media collections per sample combined into 4 aliquots/group, LDH is an average value per aliquot). (C) The swelling ratio (calculated as the ratio of wet to dry weight) indicated that injury caused gross tissue damage and swelling within 24 h post-injury. In contrast, IL-1 treatment resulted in increased swelling only after 120 h of treatment (N = 4 samples/group; all CTAs fabricated with pooled chondrocytes of a single animal). *P vs control and #P vs IL-1 for a respective time point; P < 0.001 for * and # symbols alone. Osteoarthritis and Cartilage 2014 22, 1282-1290DOI: (10.1016/j.joca.2014.06.032) Copyright © 2014 Osteoarthritis Research Society International Terms and Conditions

Fig. 5 Comparison of native and engineered cartilage injury response. Bovine cartilage explants were compressed to 75% strain at 50%/s. (A-inset) Representative peak stress profile of explants during injurious compression showing a first peak concurrent with gross tissue failure, followed by a second peak resulting from further compression of the fragments. Average first peak stress was 16.8 ± 4.3 MPa (N = 12, all explants harvested from a single animal). Soluble factors released to the medium in the first 24 h showed that (A) GAG release was comparable between injured explants and CTAs and was significantly greater than un-injured samples (N = 4 for explants, and N = 8 media collections per sample combined into 4 aliquots/group). (B) In contrast, LDH release was approximately 2-fold greater in explants compared to CTAs following injury (N = 4 for explants, and N = 8 media collections per sample combined into 4 aliquots/group). P < 0.001 for * vs control within tissue type and # vs CTAs. Osteoarthritis and Cartilage 2014 22, 1282-1290DOI: (10.1016/j.joca.2014.06.032) Copyright © 2014 Osteoarthritis Research Society International Terms and Conditions

Fig. 6 Effect of putative PTOA therapeutics on matrix content and cell death after injury. (A) LDH release 24 h post-injury was reduced by ∼30% with ZVF treatment while NAC and P188 had no effect compared to injury alone (N = 8 media collections per sample combined into 4 aliquots/group). (B) GAG content in the construct 120 h post-injury showed that NAC and P188 treatment resulted in retention of ∼20% more GAG compared to injury alone (N = 4/group). Dashed red line demarcates results from two separate experiments (CTAs for each experiment fabricated with pooled chondrocytes of a single animal) evaluating the effects of NAC, ZVF, and P188. Osteoarthritis and Cartilage 2014 22, 1282-1290DOI: (10.1016/j.joca.2014.06.032) Copyright © 2014 Osteoarthritis Research Society International Terms and Conditions